AAAAAA

   
Results: 1-8 |
Results: 8
Exon/intron boundaries, novel polymorphisms, and association analysis withschizophrenia of the human synaptic vesicle monoamine transporter (SVMT) gene
Authors: Kunugi, H Ishida, S Akahane, A Nanko, S
Citation: H. Kunugi et al., Exon/intron boundaries, novel polymorphisms, and association analysis withschizophrenia of the human synaptic vesicle monoamine transporter (SVMT) gene, MOL PSYCHI, 6(4), 2001, pp. 456-460
Design, synthesis and biological evaluation of a novel series of potent, orally active adenosine A(1) receptor antagonists with high blood-brain barrier permeability
Authors: Kuroda, S Takamura, F Tenda, Y Itani, H Tomishima, Y Akahane, A Sakane, K
Citation: S. Kuroda et al., Design, synthesis and biological evaluation of a novel series of potent, orally active adenosine A(1) receptor antagonists with high blood-brain barrier permeability, CHEM PHARM, 49(8), 2001, pp. 988-998
Novel adenosine A(1) receptor antagonists. Synthesis and structure-activity relationships of a novel series of 3-(2-cyclohexenyl-3-oxo-2,3-dihydropyridazin-6-yl)-2-phenylpyrazolo[1,5-alpha]pyridines
Authors: Kuroda, S Akahane, A Itani, H Nishimura, S Durkin, K Tenda, Y Sakane, K
Citation: S. Kuroda et al., Novel adenosine A(1) receptor antagonists. Synthesis and structure-activity relationships of a novel series of 3-(2-cyclohexenyl-3-oxo-2,3-dihydropyridazin-6-yl)-2-phenylpyrazolo[1,5-alpha]pyridines, BIO MED CH, 8(1), 2000, pp. 55-64
No evidence for an association between the Glu298Asp polymorphism of the NOS3 gene and Alzheimer's disease
Authors: Kunugi, H Akahane, A Ueki, A Otsuka, M Isse, K Hirasawa, H Kato, N Nabika, T Kobayashi, S Nanko, S
Citation: H. Kunugi et al., No evidence for an association between the Glu298Asp polymorphism of the NOS3 gene and Alzheimer's disease, J NEURAL TR, 107(8-9), 2000, pp. 1081-1084
Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-a]pyridine adenosine A(1) receptor antagonist
Authors: Kuroda, S Akahane, A Itani, H Nishimura, S Durkin, K Kinoshita, T Tenda, Y Sakane, K
Citation: S. Kuroda et al., Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-a]pyridine adenosine A(1) receptor antagonist, BIOORG MED, 9(14), 1999, pp. 1979-1984
Synthesis of the water-soluble adenosine A(1) receptor antagonist FR166124through a novel sequential Horner-Emmons/isomerization reaction
Authors: Kuroda, S Akahane, A Itani, H Nishimura, S Durkin, K Kinoshita, T Nakanishi, I Sakane, K
Citation: S. Kuroda et al., Synthesis of the water-soluble adenosine A(1) receptor antagonist FR166124through a novel sequential Horner-Emmons/isomerization reaction, TETRAHEDRON, 55(34), 1999, pp. 10351-10364
Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)pyridazinebutanoic acid (FK838): A novel non-xanthine adenosine A(1) receptor antagonist with potent diuretic activity
Authors: Akahane, A Katayama, H Mitsunaga, T Kato, T Kinoshita, T Kita, Y Kusunoki, T Terai, T Yoshida, K Shiokawa, Y
Citation: A. Akahane et al., Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)pyridazinebutanoic acid (FK838): A novel non-xanthine adenosine A(1) receptor antagonist with potent diuretic activity, J MED CHEM, 42(5), 1999, pp. 779-783
Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A(1) receptors: [S-35]GTP gamma S binding studies
Authors: Ito, H Maemoto, T Akahane, A Butcher, SP Olverman, HJ Finlayson, K
Citation: H. Ito et al., Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A(1) receptors: [S-35]GTP gamma S binding studies, EUR J PHARM, 365(2-3), 1999, pp. 309-315
Risultati: 1-8 |